205 related articles for article (PubMed ID: 29025634)
1. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.
Verguet S; Riumallo-Herl C; Gomez GB; Menzies NA; Houben RMGJ; Sumner T; Lalli M; White RG; Salomon JA; Cohen T; Foster N; Chatterjee S; Sweeney S; Baena IG; Lönnroth K; Weil DE; Vassall A
Lancet Glob Health; 2017 Nov; 5(11):e1123-e1132. PubMed ID: 29025634
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.
Menzies NA; Gomez GB; Bozzani F; Chatterjee S; Foster N; Baena IG; Laurence YV; Qiang S; Siroka A; Sweeney S; Verguet S; Arinaminpathy N; Azman AS; Bendavid E; Chang ST; Cohen T; Denholm JT; Dowdy DW; Eckhoff PA; Goldhaber-Fiebert JD; Handel A; Huynh GH; Lalli M; Lin HH; Mandal S; McBryde ES; Pandey S; Salomon JA; Suen SC; Sumner T; Trauer JM; Wagner BG; Whalen CC; Wu CY; Boccia D; Chadha VK; Charalambous S; Chin DP; Churchyard G; Daniels C; Dewan P; Ditiu L; Eaton JW; Grant AD; Hippner P; Hosseini M; Mametja D; Pretorius C; Pillay Y; Rade K; Sahu S; Wang L; Houben RMGJ; Kimerling ME; White RG; Vassall A
Lancet Glob Health; 2016 Nov; 4(11):e816-e826. PubMed ID: 27720689
[TBL] [Abstract][Full Text] [Related]
3. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
Fuady A; Houweling TAJ; Mansyur M; Richardus JH
Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
[TBL] [Abstract][Full Text] [Related]
4. Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa.
Sweeney S; Vassall A; Guinness L; Siapka M; Chimbindi N; Mudzengi D; Gomez GB
Pharmacoeconomics; 2020 Jun; 38(6):619-631. PubMed ID: 32239479
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.
Rudgard WE; Evans CA; Sweeney S; Wingfield T; Lönnroth K; Barreira D; Boccia D
PLoS Med; 2017 Nov; 14(11):e1002418. PubMed ID: 29112693
[TBL] [Abstract][Full Text] [Related]
6. Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey.
Youngkong S; Kamolwat P; Wongrot P; Thavorncharoensap M; Chaikledkaew U; Nateniyom S; Pungrassami P; Praditsitthikorn N; Mahasirimongkol S; Jittikoon J; Nishikiori N; Baena IG; Yamanaka T
Sci Rep; 2024 May; 14(1):11205. PubMed ID: 38755216
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China.
Yang T; Chen T; Che Y; Chen Q; Bo D
BMC Public Health; 2020 Jun; 20(1):1009. PubMed ID: 32586305
[TBL] [Abstract][Full Text] [Related]
8. Association of Tuberculosis With Household Catastrophic Expenditure in South India.
Muniyandi M; Thomas BE; Karikalan N; Kannan T; Rajendran K; Saravanan B; Vohra V; Okorosobo T; Lönnroth K; Tripathy SP
JAMA Netw Open; 2020 Feb; 3(2):e1920973. PubMed ID: 32049293
[TBL] [Abstract][Full Text] [Related]
9. Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis.
Ryckman TS; Schumacher SG; Lienhardt C; Sweeney S; Dowdy DW; Mirzayev F; Kendall EA
Lancet Glob Health; 2024 Jun; 12(6):e995-e1004. PubMed ID: 38762299
[TBL] [Abstract][Full Text] [Related]
10. The economic burden of TB diagnosis and treatment in South Africa.
Foster N; Vassall A; Cleary S; Cunnama L; Churchyard G; Sinanovic E
Soc Sci Med; 2015 Apr; 130():42-50. PubMed ID: 25681713
[TBL] [Abstract][Full Text] [Related]
11. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios.
Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH
Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415
[TBL] [Abstract][Full Text] [Related]
12. Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru.
Wingfield T; Boccia D; Tovar M; Gavino A; Zevallos K; Montoya R; Lönnroth K; Evans CA
PLoS Med; 2014 Jul; 11(7):e1001675. PubMed ID: 25025331
[TBL] [Abstract][Full Text] [Related]
13. Catastrophic costs among tuberculosis-affected households in Zimbabwe: A national health facility-based survey.
Timire C; Ngwenya M; Chirenda J; Metcalfe JZ; Kranzer K; Pedrazzoli D; Takarinda KC; Nguhiu P; Madzingaidzo G; Ndlovu K; Mapuranga T; Cornell M; Sandy C
Trop Med Int Health; 2021 Oct; 26(10):1248-1255. PubMed ID: 34192392
[TBL] [Abstract][Full Text] [Related]
14. The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.
Noia Maciel EL; Negri LDSA; Guidoni LM; Fregona GC; Johansen FDC; Sanchez MN; Moreira ADSR; Diaz-Quijano FA; Tonini M; Zandonade E; Ershova J; Nguhiu P; Baena IG
PLoS One; 2023; 18(12):e0287961. PubMed ID: 38091306
[TBL] [Abstract][Full Text] [Related]
15. Catastrophic costs of tuberculosis care: a mixed methods study from Puducherry, India.
Prasanna T; Jeyashree K; Chinnakali P; Bahurupi Y; Vasudevan K; Das M
Glob Health Action; 2018; 11(1):1477493. PubMed ID: 29902134
[TBL] [Abstract][Full Text] [Related]
16. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review.
Barter DM; Agboola SO; Murray MB; Bärnighausen T
BMC Public Health; 2012 Nov; 12():980. PubMed ID: 23150901
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis.
Akalu TY; Clements ACA; Wolde HF; Alene KA
Sci Rep; 2023 Dec; 13(1):22361. PubMed ID: 38102144
[TBL] [Abstract][Full Text] [Related]
18. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
Pham TAM; Forse R; Codlin AJ; Phan THY; Nguyen TT; Nguyen N; Vo LNQ; Dat PT; Minh HDT; Nguyen LH; Nguyen HB; Nguyen NV; Bodfish M; Lönnroth K; Wingfield T; Annerstedt KS
BMC Public Health; 2023 Dec; 23(1):2372. PubMed ID: 38042797
[TBL] [Abstract][Full Text] [Related]
19. Identifying costs contributing to catastrophic expenditure among TB patients registered under RNTCP in Delhi metro city in India.
Sarin R; Vohra V; Singla N; Thomas B; Krishnan R; Muniyandi M
Indian J Tuberc; 2019 Jan; 66(1):150-157. PubMed ID: 30797274
[TBL] [Abstract][Full Text] [Related]
20. Active case finding among marginalised and vulnerable populations reduces catastrophic costs due to tuberculosis diagnosis.
Shewade HD; Gupta V; Satyanarayana S; Kharate A; Sahai KN; Murali L; Kamble S; Deshpande M; Kumar N; Kumar S; Pandey P; Bajpai UN; Tripathy JP; Kathirvel S; Pandurangan S; Mohanty S; Ghule VH; Sagili KD; Prasad BM; Nath S; Singh P; Singh K; Singh R; Jayaraman G; Rajeswaran P; Srivastava BK; Biswas M; Mallick G; Bera OP; Jaisingh AJJ; Naqvi AJ; Verma P; Ansari MS; Mishra PC; Sumesh G; Barik S; Mathew V; Lohar MRS; Gaurkhede CS; Parate G; Bale SY; Koli I; Bharadwaj AK; Venkatraman G; Sathiyanarayanan K; Lal J; Sharma AK; Rao R; Kumar AMV; Chadha SS;
Glob Health Action; 2018; 11(1):1494897. PubMed ID: 30173603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
